BiomX vs TrialJectory
BiomX vs TrialJectory, compared side by side on 20 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: BiomX is on 56/100 and TrialJectory on 58/100.
Where each one leads
BiomX
- domain rating: 44/100 against 39/100
- headcount: 104 against 17
- funding raised: $56.0M against $39.7M
TrialJectory
- LinkedIn following: 4,387 against 2,986
At a glance
| Measure | BiomX | TrialJectory |
|---|---|---|
| What it is | Microbiome drug discovery company developing customized phage therapies for chronic diseases. | AI-powered platform connecting cancer patients to advanced treatments and clinical trials. |
| Category | Healthcare, Drug Discovery, Biotech, Phage Therapy | Healthcare, Clinical Trials, Cancer, HealthTech |
| Sells toBusiness model | B2B | B2B |
| Offering | Software | Software |
| Founded | 2017 | 2017 |
| Headquarters | Ness Ziona, Israel | New York, United States |
| Status | Active | Active |
Size, funding and growth
| Measure | BiomX | TrialJectory |
|---|---|---|
| Employees | 104 | 17 |
| Headcount growthLast 12 months | Not published | -33.1% |
| Total funding | $56.0M | $39.7M |
| Latest round | Series B | Series A |
| LinkedIn followers | 2,986 | 4,387 |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | BiomX | TrialJectory |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 56/100 | 58/100 |
| Traction | 59/100 | 51/100 |
| Team | 70/100 | 70/100 |
| Search visibility | 23/100 | 36/100 |
| Quality | 58/100 | 62/100 |
| Agent readinessHow well an AI agent can read and act on the site | F (29/100) | F (32/100) |
| Domain ratingLink authority, 0-100 | 44/100 | 39/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | BiomX | TrialJectory |
|---|---|---|
| Hosting | Not detected | AWS |
| CDN | Cloudflare | CloudFront |
| CMS | WordPress | Not detected |
| Frameworks | Jquery | Next.js |
| Analytics | Google Tag Manager | Not detected |
BiomX vs TrialJectory: common questions
Which is better, BiomX or TrialJectory?
On our 0-100 score TrialJectory rates higher (58/100 against 56/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 20 data points above: read the rows that match what you are buying for.
How do BiomX and TrialJectory compare on the numbers?
BiomX leads on domain rating (44/100 against 39/100), headcount (104 against 17), funding raised ($56.0M against $39.7M). TrialJectory leads on LinkedIn following (4,387 against 2,986).
Read the full BiomX review and pricing or the TrialJectory review and pricing. You can also browse other BiomX alternatives we track.